Precision Biosciences (DTIL) EBITDA Margin Growth (1y) (2019 - 2026)
Precision Biosciences (DTIL) EBITDA Margin Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Precision Biosciences |
168.99 Mn |
67.81 Mn |
- |
7.62 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
7.62 Mn |
| Dec 31, 2025 |
393,093.00 |
| Sep 30, 2025 |
-15.53 Mn |
| Jun 30, 2025 |
-12.16 Mn |
| Mar 31, 2025 |
-7.62 Mn |
| Dec 31, 2024 |
-368,279.00 |
| Sep 30, 2024 |
-359,935.00 |
| Jun 30, 2024 |
6,420.00 |
| Mar 31, 2024 |
12,828.00 |
| Dec 31, 2023 |
-9,731.00 |
| Sep 30, 2023 |
10,509.00 |
| Jun 30, 2023 |
75,785.00 |
| Mar 31, 2023 |
67,199.00 |
| Dec 31, 2022 |
37,042.00 |
| Sep 30, 2022 |
-15,130.00 |
| Jun 30, 2022 |
-80,510.00 |
| Mar 31, 2022 |
-70,945.00 |
| Dec 31, 2021 |
-21,925.00 |
| Sep 30, 2021 |
30,569.00 |
| Jun 30, 2021 |
307,485.00 |
